Altimmune (ALT) Retained Earnings (2010 - 2026)
Altimmune (ALT) reported Retained Earnings of -$5.2 million for Q1 2026, down 4.42% year-over-year from -$5.5 million in Q1 2025, and down 6.01% on a QoQ basis from -$4.9 million in Q4 2025.
Altimmune (ALT) has 17 years of Retained Earnings data on file, last reported at -$5.2 million in Q1 2026.
- Quarterly Retained Earnings fell 4.42% year-over-year to -$5.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5.2 million (down 4.42% YoY) and the FY2025 annual result came in at -$4.9 million, up 0.9% from the prior year.
- Retained Earnings slipped to -$5.2 million in Q1 2026 per ALT's latest filing, from -$4.9 million in the prior quarter.
- Across five years, Retained Earnings topped out at -$4.8 million in Q3 2024 and bottomed at -$515.4 million in Q2 2024.
- The 5-year median for Retained Earnings is -$5.2 million (2026), against an average of -$150.3 million.
- The widest annual swing landed in 2024, when Retained Earnings slumped 9520.17%; it then soared 99.02% in 2025.
- Tracing ALT's Retained Earnings over 5 years: stood at -$5.2 million in 2022, then advanced by 4.27% to -$5.0 million in 2023, then gained by 0.62% to -$5.0 million in 2024, then grew by 0.9% to -$4.9 million in 2025, then decreased by 6.01% to -$5.2 million in 2026.
- Per Business Quant, the three latest ALT Retained Earnings figures stand at -$5.2 million (Q1 2026), -$4.9 million (Q4 2025), and -$5.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -211.85 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | -153.89 Mn |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | -438.66 Mn |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -279.00 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 14.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 130.89 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 36.42 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -24.89 Mn |
| 10 | Altimmune | 379.61 Mn | 379.61 Mn | - | -5.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.22 Mn |
| Dec 31, 2025 | -4.93 Mn |
| Sep 30, 2025 | -5.02 Mn |
| Jun 30, 2025 | -5.04 Mn |
| Mar 31, 2025 | -5.00 Mn |
| Dec 31, 2024 | -4.97 Mn |
| Sep 30, 2024 | -4.85 Mn |
| Jun 30, 2024 | -515.37 Mn |
| Mar 31, 2024 | -490.73 Mn |
| Dec 31, 2023 | -5.00 Mn |
| Sep 30, 2023 | -434.69 Mn |
| Jun 30, 2023 | -414.02 Mn |
| Mar 31, 2023 | -5.10 Mn |
| Dec 31, 2022 | -5.23 Mn |
| Sep 30, 2022 | -5.30 Mn |
| Jun 30, 2022 | -332.71 Mn |
| Mar 31, 2022 | -312.60 Mn |
| Dec 31, 2021 | -293.17 Mn |
| Sep 30, 2021 | -5.04 Mn |
| Jun 30, 2021 | -235.77 Mn |
| Mar 31, 2021 | -210.94 Mn |
| Dec 31, 2020 | -5.04 Mn |
| Sep 30, 2020 | -5.04 Mn |
| Jun 30, 2020 | -158.03 Mn |
| Mar 31, 2020 | -5.05 Mn |
| Dec 31, 2019 | -137.38 Mn |
| Sep 30, 2019 | -5.02 Mn |
| Jun 30, 2019 | -5.04 Mn |
| Mar 31, 2019 | -5.04 Mn |
| Dec 31, 2018 | -5.04 Mn |
| Sep 30, 2018 | -5.04 Mn |
| Jun 30, 2018 | -5.04 Mn |
| Mar 31, 2018 | -80.86 Mn |
| Dec 31, 2017 | -4.58 Mn |
| Sep 30, 2017 | -4.71 Mn |
| Jun 30, 2017 | -5.74 Mn |
| Dec 31, 2016 | -31.26 Mn |
| Sep 30, 2016 | 12,346.00 |
| Jun 30, 2016 | -216.91 Mn |
| Mar 31, 2016 | -224.95 Mn |
| Dec 31, 2015 | -223.72 Mn |
| Sep 30, 2015 | -222.49 Mn |
| Jun 30, 2015 | -221.16 Mn |
| Mar 31, 2015 | -218.82 Mn |
| Dec 31, 2014 | -229,528.00 |
| Jun 30, 2014 | -213.03 Mn |
| Mar 31, 2014 | -212.59 Mn |
| Dec 31, 2013 | -210.33 Mn |
| Sep 30, 2013 | -205.90 Mn |
| Jun 30, 2013 | -201.96 Mn |
| Mar 31, 2013 | -200.72 Mn |
| Dec 31, 2012 | -198.61 Mn |
| Sep 30, 2012 | -197.34 Mn |
| Jun 30, 2012 | -197.13 Mn |
| Mar 31, 2012 | -196.37 Mn |
| Dec 31, 2011 | -193.69 Mn |
| Sep 30, 2011 | -194.44 Mn |
| Jun 30, 2011 | -194.41 Mn |
| Dec 31, 2010 | -189.89 Mn |